PDHB: Abruptly Branched Polyglutamylamine with Potential as A Drug Target Or Biomarker

Target Name: PDHB

NCBI ID: G5162

PDHB

PDHB: Abruptly Branched Polyglutamylamine with Potential as A Drug Target Or Biomarker

PDHB (Polyglutamyl hydrobromide), also known as E-type or N-type polyglutamylamine, is a branched amino acid that has been found to play a crucial role in various physiological processes in the body. It is a key component of the nervous system, and is also involved in the development and maintenance of tissues such as brain, heart, and liver.

PDHB has also been shown to have potential as a drug target or biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and numerous biological functions have made it an attractive target for researchers to explore.

One of the key features of PDHB is its ability to interact with various signaling pathways in the body. It has been shown to play a role in the regulation of cell growth, differentiation, and survival, as well as in the regulation of inflammation and immune responses.

PDHB has also been shown to be involved in the development and maintenance of various tissues and organs, including the brain, heart, and liver. It has been shown to be involved in the formation of new neurons, and has been shown to have a role in the regulation of neurotransmitter release and synaptic plasticity.

In addition to its role in the nervous system, PDHB has also been shown to be involved in the development and maintenance of various other tissues and organs. It has been shown to be involved in the regulation of cell growth and differentiation in the skin, and has has been shown to have a role in the development and maintenance of heart muscle.

PDHB has also been shown to have potential as a drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and numerous biological functions have made it an attractive target for researchers to explore.

One of the key features of PDHB is its ability to interact with various signaling pathways in the body. It has been shown to play a role in the regulation of cell growth, differentiation, and survival, as well as in the regulation of inflammation and immune responses.

PDHB has also been shown to be involved in the development and maintenance of various tissues and organs, including the brain, heart, and liver. It has been shown to be involved in the formation of new neurons, and has been shown to have a role in the regulation of neurotransmitter release and synaptic plasticity.

In addition to its role in the nervous system, PDHB has also been shown to be involved in the development and maintenance of various other tissues and organs. It has been shown to be involved in the regulation of cell growth and differentiation in the skin, and has has been shown to have a role in the development and maintenance of heart muscle.

PDHB has also been shown to have potential as a biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and numerous biological functions have made it an attractive target for researchers to explore.

One of the challenges in studying PDHB is its relatively small size, as it is a short chain amino acid with only 20 amino acid residues. This has made it difficult to study its full biological functions, and has limited its potential as a drug target or biomarker.

Despite these challenges, research into PDHB is still in its infancy, and there is much to be learned about its role in various physiological processes in the body. As research continues, it is likely that PDHB will be found to have a wide range of biological functions and will become a valuable drug target or biomarker for a variety of diseases.

Protein Name: Pyruvate Dehydrogenase E1 Subunit Beta

Functions: The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle

The "PDHB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDHB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets